Literature DB >> 29669702

Targeting ALK in inflammatory myofibroblastic tumours.

Victor M Villalobos1, D Ross Camidge2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29669702     DOI： 10.1016/S2213-2600(18)30147-4

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  4 in total

1.  Spontaneous pneumothorax caused by an inflammatory myofibroblastic tumor-like lesion in a 14-year-old girl: a case report.

Authors:  Hisayuki Miyagi; Daisuke Ishii; Masatoshi Hirasawa; Shunsuke Yasuda; Naohisa Toriumi; Takeo Sarashina; Mishie Tanino; Mio Tanaka; Yukichi Tanaka; Kazutoshi Miyamoto
Journal:  Surg Case Rep       Date:  2020-05-24

Review 2.  Ureteral inflammatory myofibroblastic tumor: A case report and literature review.

Authors:  Faping Li; Hui Guo; Heping Qiu; Yuchuan Hou
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

3.  Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report.

Authors:  Qiuxia Liu; Jianguo Wei; Xizhong Liu; Jianfang Wang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

4.  Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion.

Authors:  Wenguang He; Xiao Ji; Congcong Song; Shanshan Song; Lixia Liu
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.